This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Imovax Polio
Brand Name :
Imovax Polio
Generic Name :
Poliomyelitis Vaccine (Inactivated)
Partner :
Sanofi
What is this drug and what is it used for?
IMOVAX POLIO is a vaccine. Vaccines are used to protect against infectious diseases.
When IMOVAX POLIO is injected, the body’s natural defenses develop a protection against those diseases.
This vaccine is indicated for the prevention of poliomyelitis in infants, children and adults, for primary vaccination (series of first vaccinations) and as a booster. When IMOVAX POLIO is injected, the body’s natural defenses develop a protection against those diseases.
IMOVAX POLIO must be used according to effective official recommendations.
How is this drug given?
Dosage regimen compliant with French recommendations:
Pediatric population
One dose at the age of 2 months and one dose at the age of 4 months, followed by a booster dose at the age of 11 months.
Non-vaccinated adults
Two successive doses of 0.5 ml at an interval of two months, followed by a booster dose 8 to 12 months after the first injection.
Please refer to official recommendations for any further boosters.
Method of administration
This vaccine will be administered by a healthcare professional, preferably into a muscle (intramuscular route) or under the skin (subcutaneous route).
This vaccine must never be administered into a blood vessel.
Injection into a muscle will be preferably performed in the upper side of the thigh in young children and in the upper part of the arm in children, adolescents and adults.